Fennec Pharmaceuticals (FRX.TO) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.14
0.1
0.33
0.56

Details

Expected EPS
-0.078504175
Actual EPS
0.5597688999999999
Surprise EPS
0.64
Surprise Percent
+813.04%

Description

Fennec Pharmaceuticals (FRX.TO) has reported earnings of 0.5597688999999999 per share for Q2 2024.

0 Comments

Share your thoughts